In Search Of Goodwill, Several Pharmas Commit To New Corporate ‘Statement Of Purpose’
Executive Summary
The updated business principles may give pharma companies leverage, or at least talking points, as they continue to engage with the Trump administration on policies like the International Pricing Index and with US lawmakers on drug pricing legislation. J&J's Gorsky heads governing committee of multi-industry business group that revised its principles.
You may also be interested in...
J&J CEO Gorsky Handing Over The Reins To Vice Chairman Duato
Duato has been involved for the last several years in growing J&J’s pharma and consumer businesses and has led the company’s COVID-19 efforts. Gorsky is stepping down due to a family health issue.
J&J CEO Gorsky Handing Over Reins To Vice Chairman Duato
Joaquin Duato has been involved for the last several years in growing J&J’s pharma and consumer businesses and has led the company’s COVID-19 efforts. Alex Gorsky is stepping down due to a family health issue.
Trump’s Maximum Pressure Campaign On US Drug Pricing
President Trump isn’t going to let the Democrats own the drug pricing debate heading into the 2020 elections, so biopharma companies can look forward to many more headlines like the importation announcement on 31 July. When will it end?